Loxo Oncology: Out Of The Frying Pan And Into The Fire, Part 1 [Seeking Alpha]
LOXO ONCOLOGY (LOXO)
Last loxo oncology earnings: 11/8 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.loxooncology.com
Company Research
Source: Seeking Alpha
Loxo Oncology: Out Of The Frying Pan And Into The Fire, Part 1SummaryLoxo Oncology has broken ground in oncology, pioneering the basket clinical trial to evaluate drugs based on a cancer's genetic profile, along the way generating enormous returns for investors.With a probable Larotrectinib approval upcoming in November, and an expected LOXO-292 regulatory submission in late-2019, Loxo is on the verge of transitioning from clinical R&D to full-blown commercialization.Loxo is squared away to approve a targeted therapy before the infrastructure exists to affordably and reliably screen patients that are eligible for treatment at scale.It has been 14 months since we have seen updated clinical data on larotrectinib. Durability of responses presented in October at ESMO will be key to de-risking the larotrectinib franchise.In part two of this two-part series I will dive deeper into Loxo's business operations to explore how the company is positioned to transition to a commercial-stage biotech
Show less
Read more
Impact Snapshot
Event Time:
LOXO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LOXO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LOXO alerts
High impacting LOXO ONCOLOGY news events
Weekly update
A roundup of the hottest topics